Cargando…
NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program
Neurofibromatosis Type I (NF1) is caused by variants in neurofibromin (NF1). NF1 predisposes to a variety of benign and malignant tumor types, including breast cancer. Women with NF1 <50 years of age possess an up to five-fold increased risk of developing breast cancer compared with the general p...
Autores principales: | Maani, Nika, Westergard, Shelley, Yang, Joanna, Scaranelo, Anabel M., Telesca, Stephanie, Thain, Emily, Schachter, Nathan F., McCuaig, Jeanna M., Kim, Raymond H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562659/ https://www.ncbi.nlm.nih.gov/pubmed/31121919 http://dx.doi.org/10.3390/cancers11050707 |
Ejemplares similares
-
A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care
por: McCuaig, Jeanna M., et al.
Publicado: (2021) -
Incidental findings from cancer next generation sequencing panels
por: Maani, Nika, et al.
Publicado: (2021) -
A prospective pilot study of analysis of surgical margins of breast cancers using high-resolution sonography
por: Scaranelo, Anabel M., et al.
Publicado: (2016) -
Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program
por: Gold, Nicholas, et al.
Publicado: (2023) -
Psychosocial Interventions for Women with a BRCA1 or BRCA2 Mutation: A Scoping Review
por: Boghosian, Talin, et al.
Publicado: (2021)